Prevalence of Pretreatment HIV-1 Drug Resistance in Armenia in 2017–2018 and 2020–2021 following a WHO Survey

The increased antiretroviral therapy (ART) coverage of patients in the absence of routine genotyping tests and in the context of active labor migration highlight the importance of HIV-1 drug resistance (DR) surveillance in Armenia. We conducted a two-phase pretreatment DR (PDR) study in 2017–2018 (p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirichenko, Alina, Kireev, Dmitry, Lapovok, Ilya, Shlykova, Anastasia, Lopatukhin, Alexey, Pokrovskaya, Anastasia, Ladnaya, Natalya, Grigoryan, Trdat, Petrosyan, Arshak, Sarhatyan, Tatevik, Sargsyants, Narina, Hovsepyan, Tamara, Ghazaryan, Hovsep, Hovakimyan, Hermine, Martoyan, Siranush, Pokrovsky, Vadim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698750/
https://www.ncbi.nlm.nih.gov/pubmed/36366418
http://dx.doi.org/10.3390/v14112320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698750/
https://www.ncbi.nlm.nih.gov/pubmed/36366418
http://dx.doi.org/10.3390/v14112320

Ejemplares similares